Diagnostic keys for disseminated eczema: experience of a Dermatitis Contact unit (2003-2019)
DOI:
https://doi.org/10.23938/ASSN.0987Keywords:
Eczema, Pruritus, Epicutaneous patch test, Dermatitis, Allergic contactAbstract
The aim of this study was to establish the diagnoses of patients with disseminated eczema and analyze the allergens involved in disseminated eczema due to allergic contact dermatitis. We analyzed the data from patients with a diagnosis of disseminated / generalized eczema who had undergone anamnesis, physical examination and patch tests in a Contact Dermatitis consultation from 2003 to 2019.
Allergic contact dermatitis was the most frequent diagnosis, followed by atopic dermatitis, asteatotic eczema, and gravitational eczema. The allergens most frequently involved in allergic contact dermatitis were isothiazolinones, topical medications, paraphenylenediamine, and fragrances.
Allergic contact dermatitis caused almost half of the cases of disseminated eczema. It would be therefore advisable for patients with disseminated eczema to be assessed at a Contact Dermatitis unit and undergo patch tests.
Downloads
References
HERVELLA-GARCÉS M, GARCÍA-GAVÍN J, SILVESTRE-SALVADOR JF. Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC). Actualización de la serie estándar española de pruebas alérgicas de contacto por el Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC) para 2016. Actas Dermosifiliogr 2016; 107: 559-566. https://doi.org/10.1016/j.ad.2016.04.009
JOHANSEN JD, AALTO-KORTE K, AGNER T, ANDERSEN KE, BIRCHER A, BRUZE M et al. European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice. Contact Dermatitis 2015 ; 73: 195-221. https://doi.org/10.1111/cod.12432
HERVELLA M, GARCÍA-GAVÍN J, SILVESTRE JF. The Spanish standard patch test series. Actas Dermosifiliogr 2016; 107: 547-550. https://doi.org/10.1016/j.ad.2016.04.005
AQUINO M, ROSNER G. Systemic Contact Dermatitis. Clin Rev Allergy Immunol 2019; 56: 9-18. https://doi.org/10.1007/s12016-018-8686-z
MAGDALENO-TAPIAL J, VALENZUELA-OÑATE C, ORTIZ-SALVADOR JM, GARCÍA-LEGAZ-MARTÍNEZ M, MARTÍNEZ-DOMENECH Á, ALONSO-CARPIO M et al. Contact allergy to isothiazolinones epidemic: current situation. Contact Dermatitis 2020; 82: 83-86. https://doi.org/10.1111/cod.13396
SCHWENSEN JF, UTER W, BRUZE M, SVEDMAN C, GOOSSENS A, WILKINSON M et al; European Environmental Contact Dermatitis Research Group. The epidemic of methylisothiazolinone: a European prospective study. Contact Dermatitis 2017; 76: 272-279. https://doi.org/10.1111/cod.12733
BIGLIARDI PL, ALSAGOFF SAL, EL-KAFRAWI HY, PYON JK, WA CTC, VILLA MA. Povidone iodine in wound healing: A review of current concepts and practices. Int J Surg 2017; 44: 260-268. https://doi.org/10.1016/j.ijsu.2017.06.073
ENCABO DURÁN B, ROMERO-PÉREZ D, SILVESTRE SALVADOR JF. Actualización en la dermatitis de contacto alérgica por parafenilendiamina. Actas Dermosifiliogr 2018; 109: 602-609. https://doi.org/10.1016/j.ad.2017.12.007
ARRIBAS MP, SORO P, SILVESTRE JF. Allergic contact dermatitis to fragrances. Part 1. Actas Dermosifiliogr 2012; 103: 874-879. https://doi.org/10.1016/j.adengl.2012.01.022
ARRIBAS MP, SORO P, SILVESTRE JF. Allergic contact dermatitis to fragrances. Part 2. Actas Dermosifiliogr 2013; 104: 29-37. https://doi.org/10.1016/j.ad.2012.03.005
NEDOROST S. A diagnostic checklist for generalized dermatitis. Clin Cosmet Investig Dermatol 2018; 11: 545-549. https://doi.org/10.2147/CCID.S185357
SPIKER A, MOWAD C. patch test negative generalized. Dermatitis 2016; 27: 259-262. https://doi.org/10.1097/DER.0000000000000217
ZUG KA, RIETSCHEL RL, WARSHAW EM, BELSITO DV, TAYLOR JS, MAIBACH HI et al. The value of patch testing patients with a scattered generalized distribution of dermatitis: retrospective cross-sectional analyses of North American Contact Dermatitis Group data, 2001 to 2004. J Am Acad Dermatol 2008; 59: 426-431. https://doi.org/10.1016/j.jaad.2008.05.008
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Anales del Sistema Sanitario de Navarra
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
